AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease

Published:2019-10 Issue: Volume:99 Page:67-80
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Nikolaou Nikolaos,Gathercole Laura L.,Marchand Lea,Althari Sara,Dempster Niall J.,Green Charlotte J.,van de Bunt Martijn,McNeil Catriona,Arvaniti Anastasia,Hughes Beverly A.,Sgromo Bruno,Gillies Richard S.,Marschall Hanns-Ulrich,Penning Trevor M.,Ryan John,Arlt Wiebke,Hodson Leanne,Tomlinson Jeremy W.

Funder

Medical Research Council

NIHR

British Heart Foundation

National Institute of Environmental Health Sciences

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference70 articles.

1. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015

2. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology,2015